Bad Homburg, Germany

Peter Jurgen Cnota



Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Homburg, DE (2009)
  • Bad Homburg, DE (2011 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Peter Jurgen Cnota

Introduction

Peter Jurgen Cnota is a notable inventor based in Bad Homburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. With a total of four patents to his name, Cnota's work focuses on innovative combinations of medications that aim to improve patient outcomes.

Latest Patents

Cnota's latest patents include a groundbreaking combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes, glucocorticoids, and phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases. This invention relates to novel combinations that are particularly effective for respiratory diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD), as well as rheumatic or autoimmune diseases. Another significant patent involves a combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases. This pharmaceutical composition is designed to address conditions including allergic rhinitis, bronchial asthma, COPD, and the common cold.

Career Highlights

Cnota is currently associated with Meda Pharma GmbH & Co. KG, where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing treatment options for patients suffering from various inflammatory conditions.

Collaborations

Cnota has collaborated with notable colleagues such as Joachim Maus and Istvan Szelenyi, contributing to the development of effective therapeutic strategies.

Conclusion

Peter Jurgen Cnota's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving healthcare. His work continues to pave the way for advancements in the treatment of inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…